Publisher： Karger
E-ISSN： 2296-5262|27|2|150-154
ISSN： 2296-5270
Source： Oncology Research and Treatment, Vol.27, Iss.2, 2004-05, pp. : 150-154
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Very Low Doses of Thalidomide as Single Agent in Relapsed/Refractory Multiple Myeloma
Acta Haematologica, Vol. 116, Iss. 1, 2006-07 ,pp. :
Access to resources
Recommend
Low-Dose Thalidomide Treatment for Advanced Hepatocellular Carcinoma
Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. :
The Future Role of Thalidomide in Multiple Myeloma
Acta Haematologica, Vol. 114, Iss. 1, 2005-09 ,pp. :
Maintenance Therapy for Multiple Myeloma with Particular Emphasis on Thalidomide
Oncology Research and Treatment, Vol. 29, Iss. 12, 2006-12 ,pp. :
The Current Status of Thalidomide in the Management of Multiple Myeloma
Acta Haematologica, Vol. 114, Iss. 1, 2005-09 ,pp. :